Key facts
- Adonis’s last known valuation is $328.0M (Mar 2026).
- It has raised $93.9M; the latest was Later Stage VC ($40.0M) in Mar 2026.
- Notable investors include General Catalyst, Soma Capital, Everywhere Ventures, Correlation Ventures, Point72 Ventures — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Adonis
- ·The full record, as it builds
Funding rounds
No funding rounds for Adonis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Adonis
Developer of healthcare revenue intelligence and automation platform designed to streamline revenue cycle management and optimize financial success for medical providers. The company's platform leverages AI and data-driven insights to automate tasks, detect underpayments and improve claim accuracy, enabling customers to maximize revenue collection, minimize administrative burden and focus on delivering patient care.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 185
- Website
- adonis.io/
- Ownership
- Privately Held (backing)
Adonis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Adonis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Adonis in its N-PORT filings yet. We sweep new filings monthly.